Understanding Duchenne: The Role of World Duchenne Organization in BEAMER 

  (From left to right: Suzie-Ann Bakker and Dimitrios Athanasiou, World Duchenne Organization)   The role [...]

Read More
An analysis of medication adherence through Electronic Health Records (EHR) data

As researchers in Pharmacoepidemiology and Pharmacovigilance focused on studying the use, adherence, effectiveness and safety [...]

Read More
“Lighting The Way” Blog Series #6: Adherence and Effiency

Each month, we convene several partner organisations from the BEAMER project to discuss one of [...]

Read More
“Lighting The Way” Blog Series #5: Adherence and Equity

Each month, we convene several partner organisations from the BEAMER project to discuss one of [...]

Read More
“Lighting The Way” Blog Series #4: Adherence and Effectiveness

Each month, we convene several partner organisations from the BEAMER project to discuss one of [...]

Read More
“Lighting The Way” Blog Series #3: Adherence and Timeliness

Each month, we convene several partner organisations from the BEAMER project to discuss one of [...]

Read More
“Lighting The Way” Blog Series #2: Adherence and Patient-Centredness

Each month, we gather a few partner organisations from the BEAMER project to discuss one [...]

Read More
“Lighting The Way” Blog Series #1: Adherence and Safety

Each month, we gather a few partner organisations from the BEAMER project to discuss one [...]

Read More

Supported by a grant from IMI, the project has received funding from the Innovative Medicines Initiative 2 Joint Undertaking under grant agreement No 101034369. This joint undertaking receives support from the European Union’s Horizon 2020 research and innovation programme, the European Federation of Pharmaceutical Industries and Associations [EFPIA] and Link2Trials. The total budget is 11.9 M€ for a project duration of 60 months.

Disclaimer:
Information on this website reflects project owner’s views and neither IMI nor the European Union, EFPIA, or any Associated Partners are responsible for any use that may be made of the information contained therein.

Who’s Behind BEAMER
Subscribe to Newsletter
Press Office
Contact

Privacy Policy and Cookies

Follow us: